Home

указател смес мръсен differens strain of alpha synuclein in vivo nature Поздравете Движещ се главен готвач

Exposure to bacterial endotoxin generates a distinct strain of α-synuclein  fibril | Scientific Reports
Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril | Scientific Reports

Evidence of distinct α-synuclein strains underlying disease heterogeneity |  SpringerLink
Evidence of distinct α-synuclein strains underlying disease heterogeneity | SpringerLink

Frontiers | Import and Export of Misfolded α-Synuclein | Neuroscience
Frontiers | Import and Export of Misfolded α-Synuclein | Neuroscience

Evidence of distinct α-synuclein strains underlying disease heterogeneity |  SpringerLink
Evidence of distinct α-synuclein strains underlying disease heterogeneity | SpringerLink

Hsp110 mitigates α-synuclein pathology in vivo | PNAS
Hsp110 mitigates α-synuclein pathology in vivo | PNAS

Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos -  2019 - Journal of Neurochemistry - Wiley Online Library
Cellular models of alpha‐synuclein toxicity and aggregation - Delenclos - 2019 - Journal of Neurochemistry - Wiley Online Library

Structural and functional characterization of two alpha-synuclein strains |  Nature Communications
Structural and functional characterization of two alpha-synuclein strains | Nature Communications

α-synuclein strains that cause distinct pathologies differentially inhibit  proteasome | eLife
α-synuclein strains that cause distinct pathologies differentially inhibit proteasome | eLife

Propagation of α-Synuclein Strains within Human Reconstructed Neuronal  Network - ScienceDirect
Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network - ScienceDirect

Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils  to Model Parkinson's Disease in Rodents. - Abstract - Europe PMC
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson's Disease in Rodents. - Abstract - Europe PMC

Structural heterogeneity of α-synuclein fibrils amplified from patient  brain extracts | Nature Communications
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts | Nature Communications

Frontiers | New Perspectives on Roles of Alpha-Synuclein in Parkinson's  Disease | Frontiers in Aging Neuroscience
Frontiers | New Perspectives on Roles of Alpha-Synuclein in Parkinson's Disease | Frontiers in Aging Neuroscience

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies  - ScienceDirect
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies - ScienceDirect

Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease  | Frontiers in Molecular Neuroscience
Frontiers | Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease | Frontiers in Molecular Neuroscience

Discriminating α-synuclein strains in Parkinson's disease and multiple  system atrophy | Nature
Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy | Nature

Neurodegenerative diseases distinguished through protein-structure analysis
Neurodegenerative diseases distinguished through protein-structure analysis

A natural product inhibits the initiation of α-synuclein aggregation and  suppresses its toxicity | PNAS
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS

Alpha-synuclein stepwise aggregation reveals features of an early onset  mutation in Parkinson's disease | Communications Biology
Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson's disease | Communications Biology

A natural product inhibits the initiation of α-synuclein aggregation and  suppresses its toxicity | PNAS
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS

The structural differences between patient-derived α-synuclein strains  dictate characteristics of Parkinson's disease, multiple system atrophy and  dementia with Lewy bodies | SpringerLink
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies | SpringerLink

Molecules | Free Full-Text | Amyloid-Beta Peptides Trigger Aggregation of  Alpha-Synuclein In Vitro | HTML
Molecules | Free Full-Text | Amyloid-Beta Peptides Trigger Aggregation of Alpha-Synuclein In Vitro | HTML

Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies  | Nature
Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies | Nature

α-Synuclein conformational strains spread, seed and target neuronal cells  differentially after injection into the olfactory bulb | Acta  Neuropathologica Communications | Full Text
α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb | Acta Neuropathologica Communications | Full Text

Antibodies against alpha‐synuclein: tools and therapies - Vaikath - 2019 -  Journal of Neurochemistry - Wiley Online Library
Antibodies against alpha‐synuclein: tools and therapies - Vaikath - 2019 - Journal of Neurochemistry - Wiley Online Library

A natural product inhibits the initiation of α-synuclein aggregation and  suppresses its toxicity | PNAS
A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity | PNAS

Stabilization of α-synuclein oligomers using formaldehyde
Stabilization of α-synuclein oligomers using formaldehyde